Agenzia Italiana del Farmaco
Hepatitis C: update of 20 February 2023 concerning enrolled patients - Hepatitis C: update of 20 February 2023 concerning enrolled patients
Hepatitis C: update of 20 February 2023 concerning enrolled patients
AIFA has published the updated weekly data concerning treatments with new second-generation direct acting antiviral agents (DAAs) for chronic hepatitis C, as collected by AIFA Monitoring registries.
The information is contained in the page "Update on hepatitis C" accessible through the box "Related links".
Published on: 21 February 2023